Cargando…

Studying the impoverishing effects of procuring medicines: a national study

BACKGROUND: One of the main treatment procedures is through medicine prescription. Considering the rising burden of drug costs, we conducted this study to estimate the impoverishing effects of medicine on Iranian households. METHOD: We carried out calculations based on the Iranian National Household...

Descripción completa

Detalles Bibliográficos
Autores principales: Amiresmaili, Mohammadreza, Emrani, Zahra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6670235/
https://www.ncbi.nlm.nih.gov/pubmed/31366400
http://dx.doi.org/10.1186/s12914-019-0210-x
_version_ 1783440524005343232
author Amiresmaili, Mohammadreza
Emrani, Zahra
author_facet Amiresmaili, Mohammadreza
Emrani, Zahra
author_sort Amiresmaili, Mohammadreza
collection PubMed
description BACKGROUND: One of the main treatment procedures is through medicine prescription. Considering the rising burden of drug costs, we conducted this study to estimate the impoverishing effects of medicine on Iranian households. METHOD: We carried out calculations based on the Iranian National Household Survey for the year 2013. Amoxicillin, atorvastatin and metformin were the drugs selected. Three different poverty lines were applied. Impoverishment was estimated for various scenarios. Additionally, the associations of some demographic factors were tested. Excel 2013 and SPSS v.19 were used. RESULTS: Many households fell under the poverty line after purchasing drugs. Procuring original brand (OB) drugs caused more poverty than lowest-priced generic (LPG) equivalents. The logistic regression testing showed that the age, gender and literacy of the head of household and the size of the household were associated with impoverishment. CONCLUSION: This study showed that purchasing medicines increases the impoverishment risk of households. This risk is an index used to assess financial protection against health costs, which is in turn an indicator of health equity. The results will be of practical use for policymakers when addressing different scenarios of setting medicines prices as well as when considering alternatives for cost shifting for cross subsidies in pharmaceutical procurement.
format Online
Article
Text
id pubmed-6670235
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-66702352019-08-06 Studying the impoverishing effects of procuring medicines: a national study Amiresmaili, Mohammadreza Emrani, Zahra BMC Int Health Hum Rights Research Article BACKGROUND: One of the main treatment procedures is through medicine prescription. Considering the rising burden of drug costs, we conducted this study to estimate the impoverishing effects of medicine on Iranian households. METHOD: We carried out calculations based on the Iranian National Household Survey for the year 2013. Amoxicillin, atorvastatin and metformin were the drugs selected. Three different poverty lines were applied. Impoverishment was estimated for various scenarios. Additionally, the associations of some demographic factors were tested. Excel 2013 and SPSS v.19 were used. RESULTS: Many households fell under the poverty line after purchasing drugs. Procuring original brand (OB) drugs caused more poverty than lowest-priced generic (LPG) equivalents. The logistic regression testing showed that the age, gender and literacy of the head of household and the size of the household were associated with impoverishment. CONCLUSION: This study showed that purchasing medicines increases the impoverishment risk of households. This risk is an index used to assess financial protection against health costs, which is in turn an indicator of health equity. The results will be of practical use for policymakers when addressing different scenarios of setting medicines prices as well as when considering alternatives for cost shifting for cross subsidies in pharmaceutical procurement. BioMed Central 2019-07-31 /pmc/articles/PMC6670235/ /pubmed/31366400 http://dx.doi.org/10.1186/s12914-019-0210-x Text en © The Author(s). 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Amiresmaili, Mohammadreza
Emrani, Zahra
Studying the impoverishing effects of procuring medicines: a national study
title Studying the impoverishing effects of procuring medicines: a national study
title_full Studying the impoverishing effects of procuring medicines: a national study
title_fullStr Studying the impoverishing effects of procuring medicines: a national study
title_full_unstemmed Studying the impoverishing effects of procuring medicines: a national study
title_short Studying the impoverishing effects of procuring medicines: a national study
title_sort studying the impoverishing effects of procuring medicines: a national study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6670235/
https://www.ncbi.nlm.nih.gov/pubmed/31366400
http://dx.doi.org/10.1186/s12914-019-0210-x
work_keys_str_mv AT amiresmailimohammadreza studyingtheimpoverishingeffectsofprocuringmedicinesanationalstudy
AT emranizahra studyingtheimpoverishingeffectsofprocuringmedicinesanationalstudy